Author:
Van Kien P. Khau,Demaria R.
Reference103 articles.
1. Shores J, Berger KR, Murphy EA, Pyeritz RE (1994) Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan’s syndrome. N Engl J Med 330: 1335–41
2. Ladouceur M, Fermanian C, Lupoglazoff JM et al. (2007) Effect of beta-blockade on ascending aortic dilatation in children with the Marfan syndrome. Am J Cardiol 99: 406–9
3. Murdoch JL, Walker BA, Halpern BL et al. (1972) Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 286: 804–8
4. Silverman DI, Burton KJ, Gray J et al. (1995) Life expectancy in the Marfan syndrome. Am J Cardiol 75: 157–60
5. Jondeau G, Barthelet M, Baumann C et al. (2006) Recommandations sur la prise en charge médicamenteuse des atteintes aortiques du syndrome de Marfan. Arch Mal Coeur Vaiss 99: 540–6